2D Similarity-based GPCR Focused Screening Library

Currently, G protein-coupled receptors (GPCRs) are one of the most intensively studied drug targets, with more than 1/3 of approved drugs targeting GPCRs. They are substantial involved in human pathophysiology due to their pharmacological accessibility for small molecule drug discovery.

BOC Sciences can design a 2D similarity-based GPCR focused screening library based on known structure and activity data for some available GPCR-targeting compounds.

Regulation by internalisation of GPCRs. Figure 1. Regulation by internalisation of GPCRs. (Martins, S.; et al. 2012)

Library Design

  1. Firstly, a reference set of molecules with validated GPCR activity data is developed by applying a database with reliable sources
  2. Then, these compound molecules are narrowed down to meet high activity criteria, such as inhibition>50%, IC50, Ki, EC50 >1 μM, etc
  3. Next, a 2D fingerprint similarity search and Tanimoto index ≥0.85 are performed against the BOC Sciences HTS compound collection
  4. Finally, the resulting set of compounds is filtered using internal PAINS and toxicophore filters

The following are examples of the GPCR targets against:

  • Thyroid-stimulating hormone receptor
  • Beta-2 adrenergic receptor
  • Serotonin 2a (5-HT2a) receptor
  • Opioid receptors; mu & delta
  • Trace amine-associated receptor 1
  • Parathyroid hormone receptor
  • Galanin receptor 3
  • Orexin receptor 2
  • Dopamine D3 receptor
  • Corticotropin-releasing factor receptor 2/Corticotropin-releasing factor-binding protein
  • G-protein coupled receptor 183
  • Glucagon-like peptide 1 receptor
  • Mu opioid receptor
  • Nociceptin receptor
  • Adenosine A2a receptor
  • Cannabinoid CB2 receptor
  • Omega-3 fatty acid receptor 1
  • Vasopressin V2 receptor
  • Type-1 angiotensin II receptor
  • Proteinase-activated receptor 1
  • Vasopressin V1a receptor
  • G-protein coupled bile acid receptor 1
  • Histamine H3 receptor
  • Metabotropic glutamate receptor 5
  • Serotonin 1a (5-HT1a) receptor
  • Dopamine D2 receptor
  • Adenosine A1 receptor
  • Adenosine A2b receptor
  • Adenosine A3 receptor
  • Formyl peptide receptor 1
  • Lipoxin A4 receptor
  • G-protein coupled receptor 120
  • Adrenergic receptor beta
  • Vasoactive intestinal polypeptide receptor 1
  • Serotonin 2c (5-HT2c) receptor
  • Serotonin 4 (5-HT4) receptor
  • Taste receptor type 1 member 3
  • T1R1/T1R3
  • T1R2/T1R3
  • Kappa opioid receptor
  • Muscarinic acetylcholine receptor M1
  • Sphingosine 1-phosphate receptor Edg-6
  • Sphingosine 1-phosphate receptor Edg-5
  • Orexin receptor 1
  • Sphingosine 1-phosphate receptor Edg-3
  • G-protein coupled receptor 55
  • Sphingosine 1-phosphate receptor Edg-1
  • Cannabinoid CB1 receptor
  • G-protein coupled receptor 35
  • Neuropeptide Y receptor type 2
  • C-C chemokine receptor type 6
  • Neuropeptide S receptor
  • Prokineticin receptor 1
  • Corticotropin releasing factor receptor 1
  • Prokineticin receptor 2
  • Neurokinin 3 receptor
  • Serotonin 1b (5-HT1b) receptor
  • 5-hydroxytryptamine 1D receptor
  • Serotonin 6 (5-HT6) receptor
  • Beta-1 adrenergic receptor
  • Free fatty acid receptor 1
  • Melatonin receptor 1A
  • Melatonin receptor 1B
  • Dopamine D1 receptor
  • Serotonin 2b (5-HT2b) receptor
  • Neurokinin 1 receptor
  • Histamine H4 receptor
  • Cholecystokinin B receptor
  • Adenosine A2 receptor
  • Serotonin 5a (5-HT5a) receptor
  • Somatostatin receptor 5
  • Melatonin receptor

  • Dopamine D4 receptor
  • Serotonin 2 (5-HT2) receptor
  • Hydroxycarboxylic acid receptor 2
  • Alpha-1b adrenergic receptor
  • Melanin-concentrating hormone receptor 1
  • Muscarinic acetylcholine receptor M2
  • Ghrelin receptor
  • C-C chemokine receptor type 8
  • Serotonin 7 (5-HT7) receptor
  • Alpha-1a adrenergic receptor
  • Serotonin 1d (5-HT1d) receptor
  • Alpha-1d adrenergic receptor
  • Adrenergic receptor alpha-2
  • C-C chemokine receptor type 3
  • Metabotropic glutamate receptor 2
  • Cholecystokinin A receptor
  • Smoothened homolog
  • G protein-coupled receptor 44
  • GABA B receptor
  • Bradykinin B2 receptor
  • C-C chemokine receptor type 1
  • Alpha-2a adrenergic receptor
  • C-C chemokine receptor type 4
  • Platelet activating factor receptor
  • Adenosine receptor
  • Muscarinic acetylcholine receptor M4
  • Delta opioid receptor
  • Cysteinyl leukotriene receptor
  • Angiotensin II receptor
  • Muscarinic acetylcholine receptor M3
  • Muscarinic acetylcholine receptor M5
  • Alpha-2b adrenergic receptor
  • Free fatty acid receptor 2
  • Opioid receptor
  • Melanocortin receptor 4
  • Neuropeptide Y receptor type 1

  • Cysteinyl leukotriene receptor 1
  • Beta-3 adrenergic receptor
  • Neuropeptide Y receptor type 5
  • Histamine receptor H3
  • C-C chemokine receptor type 5
  • Thromboxane A2 receptor
  • C-C chemokine receptor type 2
  • Glucose-dependent insulinotropic receptor
  • Prostanoid EP3 receptor
  • Serotonin 1f (5-HT1f) receptor
  • Endothelin receptor ET-A
  • C-C chemokine receptor type 9
  • Dopamine receptor
  • Probable G-protein coupled receptor 139
  • Interleukin-8 receptor A
  • Prostanoid EP4 receptor
  • Serotonin 1 (5-HT1) receptor
  • Urotensin II receptor
  • Vasopressin V1b receptor
  • C5a anaphylatoxin chemotactic receptor
  • Type-1A angiotensin II receptor
  • Muscarinic acetylcholine receptor
  • Dopamine D5 receptor
  • Follicle stimulating hormone receptor
  • Serotonin (5-HT) receptor
  • Oxytocin receptor
  • G-protein coupled receptor ChemR23
  • Melanocortin receptor 3
  • Interleukin-8 receptors, CXCR1/CXCR2
  • C-X-C chemokine receptor type 3
  • Angiotensin II type 2 (AT-2) receptor
  • Somatostatin receptor 2
  • Bradykinin B1 receptor
  • Melanocortin receptor 1
  • Serotonin 1e (5-HT1e) receptor
  • Somatostatin receptor 3
  • Adrenergic receptor alpha
  • Free fatty acid receptor 4
  • Alpha-2c adrenergic receptor
  • Prostanoid DP receptor
  • Calcium sensing receptor
  • Metabotropic glutamate receptor 6
  • Olfactory receptor 5K1
  • Alpha adrenergic receptor 1A and 1B
  • Melanocortin receptor 5
  • Glucagon receptor
  • Probable G-protein coupled receptor 88
  • Taste receptor type 2 member 14
  • Metabotropic glutamate receptor 1
  • C-X-C chemokine receptor type 4
  • Adrenergic receptor alpha-1

2D Similarity-based GPCR Focused Screening Library Characteristics

  • At BOC Sciences, careful selection of GPCR-privileged scaffolds and common structural motifs with extension by 3D pharmacophore searches are supported to facilitate high-throughput screening for the discovery of novel GPCR ligands
  • An additional subset of 2,200 small-molecule screening compounds is also provided based on known GPCR allosteric modulators
  • No PAINS or toxic substances/unwanted functions: filtered by strict ‘Ro5-like’ physicochemical and most stringent in-house structural filters
  • Confirmed bioactivity and safety by preclinical studies and clinical trials
  • Structural diversity, significant efficacy, and cellular penetration
  • Structural document, IC50, and other chemical and biological data are provided
  • All compounds are continually updated
  • Compound cherry-picking service is provided

Table1. Physicochemical parameters for the BOC Sciences 2D Similarity-based GPCR Focused Screening Library

ParameterValue
MW200-500
ClogP-1.5-5.5
Number of Rotatable Bonds≤9
Number of H Donors≤4
Number of H Acceptors≤10
TPSA≤150
Compounds with ‘undesirable’ functionalitiesRemoved

What We Deliver

  • Delivered within 2 weeks in any customer-preferred format
  • Powders, dry films or DMSO solutions formatted in vials, 96 or 384-well plates
  • All compounds have a minimum purity of 90% assessed by 1H NMR and HPLC
  • Analytical data is provided

BOC Sciences provides professional, rapid and high-quality services of 2D Similarity-based GPCR Focused Screening Library design at competitive prices for global customers. Personalized and customized services of 2D Similarity-based GPCR Focused Screening Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!

Reference

  1. Martins, S.; et al. GPCR screening and drug discovery: Challenges and latest trend. European Pharmaceutical Review. 2012. 17(2).
Our mission is to provide clients with a professional chemical library design platform. Empowered by high-quality services and effective research solutions, we are committed to helping customers achieve effective and successful research goals.

Online Inquiry

Verification code
Services Based on the Chemical Library Design Platform

Services Based on the Chemical Library Design Platform

BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.

BACK TO TOP